Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
100988-5 Phosphoglucomutase CCnc Fibroblasts Pt Qn &nbsp; &nbsp; ACTIVE Phosphoglucomutase [Enzymatic activity/volume] in Fibroblast &nbsp; MIN DefinitionDescription &nbsp; &nbsp; U/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 100988-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Phosphoglucomutase Fib-cCnc &nbsp; &nbsp; &nbsp; N &nbsp; Catalytic Concentration; Chemistry; Fib; Fibr; PGM; Point in time; QNT; Quan; Quant; Quantitative; Random 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; U/L &nbsp; &nbsp; &nbsp; 0
100989-3 Phosphoglucomutase CCnc WBC Pt Qn &nbsp; &nbsp; ACTIVE Phosphoglucomutase [Enzymatic activity/volume] in Leukocytes &nbsp; MIN DefinitionDescription &nbsp; &nbsp; U/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 100989-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Phosphoglucomutase WBC-cCnc &nbsp; &nbsp; &nbsp; N &nbsp; Catalytic Concentration; Chemistry; Leukocytes; PGM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; U/L &nbsp; &nbsp; &nbsp; 0
10099-0 ST slope.lead III ElpotRat Heart Pt Qn EKG &nbsp; ACTIVE ST slope in lead III &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV/s &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10099-0 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ST Slope L-III &nbsp; &nbsp; &nbsp; Y &nbsp; 3; Amperage; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Slope L-III; Voltage rate 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV/s &nbsp; &nbsp; &nbsp; 0
100990-1 Blood group antigens panel - RBC^Father Pt - &nbsp; &nbsp; ACTIVE Fathers Blood group antigens panel &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.BLDBK &nbsp; 100990-1 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Bld Grp Ag Pnl RBC Father &nbsp; &nbsp; &nbsp; N &nbsp; Ag; Bld Grp Ag Pnl; BLOOD BANK; Erythrocytes; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Red blood cells; Red blood corpusles 2.75 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100991-9 CD52 cell expression evaluation Find XXX Pt Doc Flow cytometry &nbsp; ACTIVE CD52 cell expression evaluation in Specimen Document by Flow cytometry (FC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 100991-9 &nbsp; Flow cytometry &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD52 cell express eval Spec Doc FC &nbsp; &nbsp; &nbsp; N &nbsp; Assessment; CELL MARKERS; Document; Dynamic; Eval; FC; Finding; Findings; H&P; History and physical; Misc; Miscellaneous; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100992-7 CD20 cell expression evaluation Find XXX Pt Doc Flow cytometry &nbsp; ACTIVE CD20 cell expression evaluation in Specimen Document by Flow cytometry (FC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 100992-7 &nbsp; Flow cytometry &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Spec Doc FC &nbsp; &nbsp; &nbsp; N &nbsp; Assessment; B1; B-1; Bp35; CELL MARKERS; Document; Dynamic; Eval; FC; Finding; Findings; H&P; History and physical; Leu16; Leu-16; Misc; Miscellaneous; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100993-5 CD49d cell expression evaluation Find XXX Pt Doc Flow cytometry &nbsp; ACTIVE CD49d cell expression evaluation in Specimen Document by Flow cytometry (FC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 100993-5 &nbsp; Flow cytometry &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Spec Doc FC &nbsp; &nbsp; &nbsp; N &nbsp; Alpha-4 integrin chain; Assessment; CELL MARKERS; Document; Dynamic; Eval; FC; Finding; Findings; H&P; History and physical; Misc; Miscellaneous; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; VLA-4 alpha chain 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100994-3 B-cell CD19 & CD20 subsets panel - Bld Pt - Flow cytometry &nbsp; ACTIVE B-cell CD19 and CD20 subsets panel - Blood by Flow cytometry (FC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CELLMARK &nbsp; 100994-3 &nbsp; Flow cytometry &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Bld FC &nbsp; &nbsp; &nbsp; N &nbsp; B Cell; B1; B-1; B4; B-4; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; Blood; Bp35; CELL MARKERS; Dynamic; FC; HD-37; Leu12; Leu-12; Leu16; Leu-16; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; WB; Whole blood 2.75 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100995-0 Laceyella sacchari Ab.IgG PrThr Ser Pt Ord &nbsp; &nbsp; ACTIVE Laceyella sacchari IgG Ab [Presence] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 100995-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Laceyella sacchari IgG Ser Ql &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Thermoactinomyces sacchari 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100996-8 Neurofilament light chain MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Neurofilament light chain [Mass/volume] in Cerebral spinal fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ng/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 100996-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Nfl chain CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cerebral spinal fluid; Cerebrospinal Fl; Chains; Chemistry; Chn; Level; Mass concentration; NfL; Nfl chain; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/L &nbsp; &nbsp; &nbsp; 0
100997-6 Respiratory Allergen Panel, Area 5 - Ser Pt - &nbsp; &nbsp; ACTIVE Respiratory Allergen Panel, Area 5 - Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.ALLERGY &nbsp; 100997-6 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Respiratory Allergen Panel, Area 5 Ser &nbsp; &nbsp; &nbsp; N &nbsp; Allergen; Allergens; ALLERGY TESTING; Alrgen; Pan; PANEL.ALLERGY; Panl; Pnl; Point in time; Random; Resp allergen Pnl; Serum; SR 2.75 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100998-4 Cortisol post dose insulin IV panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Cortisol post dose insulin IV panel - Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHAL &nbsp; 100998-4 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Cortisol post dose insulin IV pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; HUM; Humulin; hydrocortisone; IH7; Insul; Lente; NPH; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.75 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
100999-2 Somatotropin post dose insulin IV panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Somatotropin post dose insulin IV panel - Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHAL &nbsp; 100999-2 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 GH post dose insulin IV pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; After; CHEMISTRY.CHALLENGE TESTING; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; NPH; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente 2.75 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101-6 Cefoperazone Susc Isolate Pt OrdQn Agar diffusion &nbsp; ACTIVE Cefoperazone [Susceptibility] by Disk diffusion (KB) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 101-6 &nbsp; Agar diffusion &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cefoperazone Islt KB &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefobid; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
1010-8 E super little w Ab PrThr Ser/Plas^BPU Pt Ord &nbsp; &nbsp; ACTIVE E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 1010-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 E sup(w) Ab SerPl BPU Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); E sup(w); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR 2.63 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Added 'super' to indicate the 'w' is a superscript to the E antigen. 0
10100-6 ST slope.lead V1 ElpotRat Heart Pt Qn EKG &nbsp; ACTIVE ST slope in lead V1 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV/s &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10100-6 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ST Slope L-V1 &nbsp; &nbsp; &nbsp; Y &nbsp; Amperage; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Slope L-V1; Voltage rate 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV/s &nbsp; &nbsp; &nbsp; 0
101000-8 Health informatics leader and champion of semantic interoperability Hx ^Patient Pt Nar &nbsp; &nbsp; ACTIVE Health informatics leader and champion of semantic interoperability &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; H&P.HX &nbsp; 101000-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Health Info Leader+Champion of Interop &nbsp; &nbsp; &nbsp; N &nbsp; Dan Vreeman; Dr. Daniel J. Vreeman; H+P; H+P.HX; History; Honorary; Informatics leader+champion of interoperability; Narrative; P prime; Point in time; Random; Report 2.77 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101001-6 Chief technical architect and steadfast leader of LOINC Hx ^Patient Pt Nar &nbsp; &nbsp; ACTIVE Chief technical architect and steadfast leader of LOINC &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; H&P.HX &nbsp; 101001-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Chief Architect+Leader of LOINC &nbsp; &nbsp; &nbsp; N &nbsp; Chief Architect+leader of LOINC; H+P; H+P.HX; History; Honorary; John Hook; John L. Hook; Logical Observation Identifiers Names and Codes; Narrative; P prime; Point in time; Random; Report 2.77 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101002-4 Monkeypox virus sequencing panel - XXX Pt - Sequencing &nbsp; ACTIVE Monkeypox virus sequencing panel - Specimen by Sequencing &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.MICRO &nbsp; 101002-4 &nbsp; Sequencing &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 MVPX sequencing panel Spec Seq &nbsp; &nbsp; &nbsp; N &nbsp; high-throughput sequencing; HTS; Microbiology; Misc; Miscellaneous; MVPX; MVPX sequencing panel; Next generation sequencing; NGS; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified 2.75 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101003-2 Monkeypox virus clade Type XXX Pt Nom Sequencing &nbsp; ACTIVE Monkeypox virus clade [Type] in Specimen by Sequencing &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 101003-2 &nbsp; Sequencing &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 MVPX clade Spec Seq &nbsp; &nbsp; &nbsp; N &nbsp; high-throughput sequencing; HTS; Microbiology; Misc; Miscellaneous; MVPX; MVPX clade; Next generation sequencing; NGS; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Typ; Unspecified 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101004-0 Monkeypox virus lineage Type XXX Pt Nom Sequencing &nbsp; ACTIVE Monkeypox virus lineage [Type] in Specimen by Sequencing &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 101004-0 &nbsp; Sequencing &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 MVPX lineage Spec Seq &nbsp; &nbsp; &nbsp; N &nbsp; high-throughput sequencing; HTS; Microbiology; Misc; Miscellaneous; MVPX; MVPX lineage; Next generation sequencing; NGS; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Typ; Unspecified 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101005-7 Discharge summary note Find {Setting} Pt Doc Hospitalist &nbsp; ACTIVE Hospitalist Discharge summary &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101005-7 &nbsp; Hospitalist &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Hospitalist Discharge sum &nbsp; &nbsp; &nbsp; N &nbsp; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note 2.74 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101006-5 Discharge summary note Find {Setting} Pt Doc Osteopathic medicine &nbsp; ACTIVE Osteopathic medicine Discharge summary &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101006-5 &nbsp; Osteopathic medicine &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Osteopathic med D/C sum &nbsp; &nbsp; &nbsp; N &nbsp; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note 2.74 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101007-3 Discharge summary note Find {Setting} Pt Doc Chiropody &nbsp; ACTIVE Chiropody Discharge summary &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101007-3 &nbsp; Chiropody &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Chiropody Discharge sum &nbsp; &nbsp; &nbsp; N &nbsp; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note 2.74 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101008-1 History and physical note Find {Setting} Pt Doc Medical aid in dying &nbsp; ACTIVE Medical Aid in Dying History and physical note &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101008-1 &nbsp; Medical aid in dying &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 MAiD H&P note &nbsp; &nbsp; &nbsp; N &nbsp; Assisted suicide; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; MAiD; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Random; Visit note 2.74 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
108,248 results found